300791 Stock Overview
Operates as a contract manufacturer for dietary supplement industry worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Sirio Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.10 |
| 52 Week High | CN¥33.37 |
| 52 Week Low | CN¥18.65 |
| Beta | 0.73 |
| 11 Month Change | -10.47% |
| 3 Month Change | -23.06% |
| 1 Year Change | 1.90% |
| 33 Year Change | -54.26% |
| 5 Year Change | n/a |
| Change since IPO | -14.27% |
Recent News & Updates
Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01
Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Recent updates
Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares
Aug 01Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around
Jun 30Is Sirio Pharma (SZSE:300791) A Risky Investment?
Jun 12An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued
Apr 24Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly
Mar 06Shareholder Returns
| 300791 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 8.0% | 4.7% | 3.3% |
| 1Y | 1.9% | -31.9% | -19.1% |
Return vs Industry: 300791 exceeded the CN Personal Products industry which returned -35.4% over the past year.
Return vs Market: 300791 exceeded the CN Market which returned -21.8% over the past year.
Price Volatility
| 300791 volatility | |
|---|---|
| 300791 Average Weekly Movement | 4.9% |
| Personal Products Industry Average Movement | 4.9% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 300791's share price has been volatile over the past 3 months.
Volatility Over Time: 300791's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 2,610 | Peiqing Li | www.siriopharma.com |
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging.
Sirio Pharma Co., Ltd. Fundamentals Summary
| 300791 fundamental statistics | |
|---|---|
| Market cap | CN¥5.41b |
| Earnings (TTM) | CN¥314.67m |
| Revenue (TTM) | CN¥3.83b |
17.2x
P/E Ratio1.4x
P/S RatioIs 300791 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300791 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.83b |
| Cost of Revenue | CN¥2.66b |
| Gross Profit | CN¥1.17b |
| Other Expenses | CN¥860.29m |
| Earnings | CN¥314.67m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
| Earnings per share (EPS) | 1.34 |
| Gross Margin | 30.67% |
| Net Profit Margin | 8.21% |
| Debt/Equity Ratio | 36.1% |
How did 300791 perform over the long term?
See historical performance and comparison